Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

PHASE3CompletedINTERVENTIONAL

Enrollment

587

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

HypercholesterolemiaHypertriglyceridemia

Interventions

DRUG

MK0653, ezetimibe

DRUG

Comparator: fenofibrate monotherapy

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092560 - Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) | Biotech Hunter | Biotech Hunter